Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Treatment of liver transplant graft-versus-host disease with antibodies against tumor necrosis factor-α.

Blank G, Li J, Kratt T, Handgretinger R, Königsrainer A, Nadalin S.

Exp Clin Transplant. 2013 Feb;11(1):68-71.

2.

Acute graft-versus-host disease after liver transplant: novel use of etanercept and the role of tumor necrosis factor alpha inhibitors.

Thin L, Macquillan G, Adams L, Garas G, Seow C, Cannell P, Augustson B, Mitchell A, Delriveire L, Jeffrey G.

Liver Transpl. 2009 Apr;15(4):421-6. doi: 10.1002/lt.21704.

3.

Graft-versus-host disease after liver transplantation complicated by systemic aspergillosis with pancarditis.

Romagnuolo J, Jewell LD, Kneteman NM, Bain VG.

Can J Gastroenterol. 2000 Jul-Aug;14(7):637-40.

PMID:
10978951
4.

Acute graft versus host disease following living donor liver transplantation: first Korean report.

Cho EH, Suh KS, Yang SH, Lee HW, Cho JY, Cho YB, Yi NJ, Lee KU.

Hepatogastroenterology. 2007 Oct-Nov;54(79):2120-2.

PMID:
18251173
5.

Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: a case report.

Piton G, Larosa F, Minello A, Becker MC, Mantion G, Aubin F, Deconinck E, Hillon P, Di Martino V.

Liver Transpl. 2009 Jul;15(7):682-5. doi: 10.1002/lt.21793.

6.

Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer.

Ringdén O, Söderdahl G, Mattsson J, Uzunel M, Remberger M, Hentschke P, Hägglund H, Sparrelid E, Elmhorn-Rosenborg A, Duraj F, Zetterquist H, Ericzon BG.

Transplantation. 2000 May 27;69(10):2043-8.

PMID:
10852594
7.

Chronic graft-versus-host disease after liver transplantation: a case report.

Yilmaz M, Ozdemir F, Akbulut S, Ersan V, Koc C, Koc S, Yilmaz S.

Transplant Proc. 2012 Jul-Aug;44(6):1751-3. doi: 10.1016/j.transproceed.2012.05.036.

PMID:
22841262
8.

Severe, late-onset graft-versus-host disease in a liver transplant recipient documented by chimerism analysis.

Pollack MS, Speeg KV, Callander NS, Freytes CO, Espinoza AA, Esterl RM, Abrahamian GA, Washburn WK, Halff GA.

Hum Immunol. 2005 Jan;66(1):28-31.

PMID:
15620459
9.

Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody.

Kobbe G, Schneider P, Rohr U, Fenk R, Neumann F, Aivado M, Dietze L, Kronenwett R, Hünerlitürkoglu A, Haas R.

Bone Marrow Transplant. 2001 Jul;28(1):47-9.

10.

Fatal GvHD as a complication of liver transplantation for undetermined fulminant hepatic failure and associated aplastic anemia.

Schäppi MG, Belli DC, Rimensberger PC, Chardot C, Kaya G, Tiercy JM, Ozsahin H.

Liver Transpl. 2006 Nov;12(11):1693-7.

11.

Rash and pancytopenia as initial manifestations of acute graft-versus-host disease after liver transplantation.

Whalen JG, Jukic DM, English JC 3rd.

J Am Acad Dermatol. 2005 May;52(5):908-12.

PMID:
15858489
12.

Abatacept use in graft-versus-host disease after orthotopic liver transplantation: a case report.

Elfeki MA, Genco PV, Pungpapong S, Nakhleh RE, Nguyen JH, Harnois DM.

Transplant Proc. 2014 Sep;46(7):2422-5. doi: 10.1016/j.transproceed.2014.06.061.

PMID:
25242798
13.

Acute graft-versus-host disease after liver transplantation diagnosed by fluorescent in situ hybridization testing of skin biopsy specimens.

Meves A, el-Azhary RA, Talwalkar JA, Moore SB, Brewer JD, Motsonelidze C, McNallan KT, Reed AM, Rosen CB.

J Am Acad Dermatol. 2006 Oct;55(4):642-6.

PMID:
17010745
14.

Infliximab treatment for steroid-refractory acute graft-versus-host disease.

Patriarca F, Sperotto A, Damiani D, Morreale G, Bonifazi F, Olivieri A, Ciceri F, Milone G, Cesaro S, Bandini G, Dini G, Corradini P, Fanin R.

Haematologica. 2004 Nov;89(11):1352-9.

15.

Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses.

Korngold R, Marini JC, de Baca ME, Murphy GF, Giles-Komar J.

Biol Blood Marrow Transplant. 2003 May;9(5):292-303.

16.

Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation.

Taylor AL, Gibbs P, Sudhindran S, Key T, Goodman RS, Morgan CH, Watson CJ, Delriviere L, Alexander GJ, Jamieson NV, Bradley JA, Taylor CJ.

Transplantation. 2004 Feb 15;77(3):441-6.

PMID:
14966423
17.

Liver transplant-associated graft-versus-host disease.

Smith DM, Agura E, Netto G, Collins R, Levy M, Goldstein R, Christensen L, Baker J, Altrabulsi B, Osowski L, McCormack J, Fichtel L, Dawson DB, Domiati-Saad R, Stone M, Klintmalm G.

Transplantation. 2003 Jan 15;75(1):118-26.

PMID:
12544883
18.

Solid organ transplant-associated acute graft-versus-host disease.

Zhang Y, Ruiz P.

Arch Pathol Lab Med. 2010 Aug;134(8):1220-4. doi: 10.1043/2008-0679-RS.1. Review.

PMID:
20670147
19.

Diagnosis and treatment for graft-versus-host disease after liver transplantation: two case reports.

Wang B, Lu Y, Yu L, Liu C, Wu Z, Liu X.

Transplant Proc. 2007 Jun;39(5):1696-8.

PMID:
17580224
20.

The utility of fluorescence in situ hybridization (FISH) analysis in diagnosing graft versus host disease following orthotopic liver transplant.

Post GR, Black JS, Cortes GY, Pollack RB, Wolff DJ, Lazarchick J.

Ann Clin Lab Sci. 2011 Spring;41(2):188-92.

PMID:
21844579
Items per page

Supplemental Content

Support Center